Sign Up
S 4150 New York Senate · 2025 Regular Session

Relates to the availability of opioid reversal agents

Summary
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.
Issues: ✓ HealthcareSupports HealthcareMandates availability of FDA-approved opioid reversal agents, improving emergency access to life-saving treatment for opioid overdoses.95% confidence
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 3, 2025 Last action Jan 7, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
2
Jan 7, 2026
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
upper
Feb 3, 2025
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
upper
1 primary · 9 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Pete Harckham
Pete Harckham
DDemocratic/Working Families
NY
40
Co
Photo of Chris Ryan
Chris Ryan
DDemocratic
NY
50
Co
Photo of Jake Ashby
Jake Ashby
RRepublican/Conservative
NY
43
Co
Photo of James Skoufis
James Skoufis
DDemocratic
NY
42
Co
Photo of Jeremy Cooney
Jeremy Cooney
DDemocratic/Working Families
NY
56
Co
Photo of Joe Addabbo
Joe Addabbo
DDemocratic
NY
15
Co
Photo of Luis Sepúlveda
Luis Sepúlveda
DDemocratic
NY
32
Co
Photo of Pat Fahy
Pat Fahy
DDemocratic
NY
46
Co
Photo of Patrick Gallivan
Patrick Gallivan
RRepublican/Conservative
NY
60
Co
Photo of Peter Oberacker
Peter Oberacker
RRepublican/Conservative
NY
51